|
Cambrex
primary human skeletal muscle myoblasts hsmm Primary Human Skeletal Muscle Myoblasts Hsmm, supplied by Cambrex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+skeletal+muscle+myoblasts+(hsmm/human+skeletal+muscle+myoblast++hsmm++cells/pmc03086889-40-0-6 Average 90 stars, based on 1 article reviews
primary human skeletal muscle myoblasts hsmm - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Cambrex
human skeletal myoblasts Human Skeletal Myoblasts, supplied by Cambrex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+skeletal+muscle+myoblasts+(hsmm/human+skeletal+muscle+myoblasts++hsmm/10__1161_slash_circresaha__108__176248-403-11-17 Average 90 stars, based on 1 article reviews
human skeletal myoblasts - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Applied Biological Materials Inc
human skeletal muscle myoblast cell lines hsmm-1 ![]() Human Skeletal Muscle Myoblast Cell Lines Hsmm 1, supplied by Applied Biological Materials Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+skeletal+muscle+myoblasts+(hsmm/human+skeletal+muscle+myoblast+cell+lines+hsmm+1/pmc07097925-52-0-17 Average 90 stars, based on 1 article reviews
human skeletal muscle myoblast cell lines hsmm-1 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
D-HSMM, Skeletal Muscle Myoblasts, Diabetes T2
|
Buy from Supplier |
|
Cryopreserved ampule of Human Skeletal Muscle Myoblasts containing ≥ 500,000 cells
|
Buy from Supplier |
|
D-HSMM, Skeletal Muscle Myoblasts, Diabetes T1
|
Buy from Supplier |
Image Search Results
Journal: International Journal of Biological Sciences
Article Title: Inflammation-dependent downregulation of miR-532-3p mediates apoptotic signaling in human sarcopenia through targeting BAK1
doi: 10.7150/ijbs.41641
Figure Lengend Snippet: miR-532-3p specifically bond to the 3′-UTR of BAK1 and negatively regulated its expression. (A) Schematic representation of the BAK1 gene and the binding site of miR-532-3p. The 5′-UTR, exons, introns and 3′-UTR of the BAK1 gene are shown. Its 3′-UTR has a putative miR-532-3p binding site located between positions 929 and 936 after TCA. (B) The wild-type and mutated sequences of BAK1 3′-UTR. Two vectors, pCDNA3-BAK1-3′-UTR WT and pCDNA3-BAK1-3′-UTR Mut, were constructed. In the mutant vector, the putative binding site of miR-532-3p was mutated and was indicated by the blue font. (C and D) BAK1 was a direct target of miR-532-3p. The pCDNA3-BAK1-3′-UTR WT and pCDNA3-BAK1-3′-UTR Mut vectors were combined with or without miR-532-3p-mimic and anti-miR-532-3p and transfected into HSMM-1 cells. After incubation for 48 h, cells were harvested and used for RNA isolation, followed by the examination of the expression levels of miR-532-3p (C) and BAK1 (D) . ** P < 0.01 and *** P < 0.001.
Article Snippet:
Techniques: Expressing, Binding Assay, Construct, Mutagenesis, Plasmid Preparation, Transfection, Incubation, Isolation
Journal: International Journal of Biological Sciences
Article Title: Inflammation-dependent downregulation of miR-532-3p mediates apoptotic signaling in human sarcopenia through targeting BAK1
doi: 10.7150/ijbs.41641
Figure Lengend Snippet: LPS treatment could affect the expression of miR-532-3p and BAK1 and their downstream molecules. (A) Serum levels of BAK1 were significantly elevated. Serum samples from 24 healthy and 24 sarcopenia patients were used to measure circulating BAK1 concentrations using ELISA. *** P < 0.001. (B) BAK1 and its downstream caspase cascades were activated in sarcopenia samples. Three-paired muscle tissues from healthy controls and sarcopenia patients were used to detect the protein levels of BAK1, Caspase-3 and Caspase-9. GAPDH was used as a loading control. F: full length; C: cleaved length. (C) LPS induced the expression of BAK1 . Three cell lines, HSMM-1, HSMM-2 and LHCN-M2, were treated with 200 ng/mL LPS for 6 h, followed by RNA isolation and qRT-PCR analyses to measure the mRNA level of BAK1 . *** P < 0.001. (D) LPS induced the BAK1 protein level and its downstream caspase cascades. The cells used in (C) were subjected to protein extraction, followed by the detection of the BAK1, Caspase-3 and Caspase-9 protein levels. GAPDH was used as a loading control. (E-G) The combined effects of miR-532-3p-mimic/anti-miR-532-3p and LPS treatment. The HSMM-1 and HSMM-2 cells were primarily transfected with miR-532-3p-mimic or anti-miR-532-3p. After 48 h, cells were treated with 200 ng/mL LPS for 6 h and then were collected and subjected to RNA isolation and protein extraction. The resulting RNA and protein extracts used for the detection of the expression of miR-532-3p (E) , BAK1 mRNA (F) , and BAK1 and caspase protein levels (G) . *** P < 0.001.
Article Snippet:
Techniques: Expressing, Enzyme-linked Immunosorbent Assay, Control, Isolation, Quantitative RT-PCR, Protein Extraction, Transfection
Journal: International Journal of Biological Sciences
Article Title: Inflammation-dependent downregulation of miR-532-3p mediates apoptotic signaling in human sarcopenia through targeting BAK1
doi: 10.7150/ijbs.41641
Figure Lengend Snippet: NFKB1/p50 specifically repressed the expression of miR-532-3p. (A) The transcription factor binding sites in the promoter of miR-532-3p. A 2000 bp-length promoter fragment was used to predict the transcription factor binding sites. The binding positions of NFKB1 (p50), STAT1 and AP-1 were indicated. (B-I) The effects of overexpressing or downregulating different transcription factors on miR-532-3p level. HSMM-1 and HSMM-2 cells were transfected with individual transcription factor-specific siRNAs and the corresponding overexpression vectors to generate the knockdown (KD) and overexpression (OE) cells. The resulting cells were subjected to RNA isolation, followed by the measurement of miR-532-3p level using qRT-PCR analyses. (B and C) The expression levels of NFKB1 (B) and miR-532-3p (C) in NFKB1-KD and NFKB1-OE cells. *** P < 0.001. (D and E) The expression levels of STAT1 (D) and miR-532-3p (E) in STAT1-KD and STAT1-OE cells. *** P < 0.001. (F and G) The expression levels of c-JUN (F) and miR-532-3p (G) in c-JUN-KD and c-JUN-OE cells. *** P < 0.001. (H and I) The expression levels of c-FOS (H) and miR-532-3p (I) in c-FOS-KD and c-FOS-OE cells. *** P < 0.001.
Article Snippet:
Techniques: Expressing, Binding Assay, Transfection, Over Expression, Knockdown, Isolation, Quantitative RT-PCR
Journal: International Journal of Biological Sciences
Article Title: Inflammation-dependent downregulation of miR-532-3p mediates apoptotic signaling in human sarcopenia through targeting BAK1
doi: 10.7150/ijbs.41641
Figure Lengend Snippet: p50 specifically bond to the promoter of miR-532-3p to repress its expression. (A) The occupancy of p50 on the promoter of miR-532-3p. The HSMM-1, HSMM1-NFKB1-KD and HSMM1-NFKB1-OE cells were subjected to ChIP assays using anti-p50, anti-STAT1 and IgG antibodies, followed by qRT-PCR analyses to measure the enrichment of p50 on the promoter of miR-532-3p. *** P < 0.001. (B) LPS treatment decreased miR-532-3p level. The HSMM-1, HSMM1-NFKB1-KD and HSMM1-NFKB1-OE cells were treated with or without 200 ng/mL LPS for 6 h, followed by RNA isolation and qRT-PCR to measure miR-532-3p level. ** P < 0.01 and *** P < 0.001. ( C) LPS treatment increased the occupancy of p50 on the promoter of miR-532-3p. The cells used in (B) were subjected to ChIP assays with anti-p50 and anti-STAT1 antibodies, followed by qRT-PCR analyses to measure the enrichment of p50 and STAT1 on the promoter of miR-532-3p. (D and E) The blockage of upstream NF-κB signaling prevented the translocation of p50 from the cytoplasm to the nucleus. HSMM-1 cells were primarily treated with the TLR4 inhibitor CLI-095 and the MyD88 inhibitor NBP2-29328 for 6 h, followed by treatment with 200 ng/mL LPS for 6 h. The resulting cells were subjected to total protein extraction and the isolation of cytoplasmic and nuclear protein fractions. The protein levels of TLR4, MyD88, TRAF4, p50 and p65 were determined by immunoblot analyses. GAPDH, β-actin and HDAC1 were used as loading controls. (F and G) The blockage of upstream NF-κB signaling blocked the effect of LPS on miR-532-3p expression. The cells used in (D) were used for RNA isolation, followed by qRT-PCR analyses to examine the expression of miR-532-3p (F) and BAK1 (G) . (I) The blockage of upstream NF-κB signaling decreased the occupancy of p50 on the promoter of miR-532-3p. The cells used in (D) were used for ChIP assays with anti-p50, anti-STAT1 and IgG antibodies, followed by qRT-PCR analyses to measure the enrichment of p50 and STAT1 on the promoter of miR-532-3p. *** P < 0.001.
Article Snippet:
Techniques: Expressing, Quantitative RT-PCR, Isolation, Translocation Assay, Protein Extraction, Western Blot